Grupo de Investigación en Cáncer de Mama
NEONCOBREAST
![Foto de Grupo de Investigación en Cáncer de Mama](/img/uploaded/46084eb269a9135ee7dc8a58bb36982a.jpg)
![Foto de Hospital Clinico Universitario de Valencia](/img/noimage_org.png)
Hospital Clinico Universitario de Valencia
Valencia, EspañaPublicaciones en colaboración con investigadores/as de Hospital Clinico Universitario de Valencia (7)
2021
2020
-
A retrospective, multicenter study of the efficacy of lapatinib plus trastuzumab in HER2-positive metastatic breast cancer patients previously treated with trastuzumab, lapatinib, or both: the Trastyvere study
Clinical and Translational Oncology, Vol. 22, Núm. 3, pp. 420-428
-
Axillary staging based on molecular analysis: Results of the B-CLOSER-II study
Pathology Research and Practice, Vol. 216, Núm. 11
-
Palbociclib combined with endocrine therapy in heavily pretreated HR+/HER2- advanced breast cancer patients: Results from the compassionate use program in Spain (PALBOCOMP)
Breast, Vol. 54, pp. 286-292
2019
-
Neoadjuvant Management of Early Breast Cancer: A Clinical and Investigational Position Statement
Oncologist, Vol. 24, Núm. 5, pp. 603-611
-
Prospective external validation of IOTA three-step strategy for characterizing and classifying adnexal masses and retrospective assessment of alternative two-step strategy using simple-rules risk
Ultrasound in Obstetrics and Gynecology, Vol. 53, Núm. 5, pp. 693-700
2015
-
Patterns of HER2 gene amplification and response to anti-HER2 therapies
PLoS ONE, Vol. 10, Núm. 6